Syrris’ Free Flow Chemistry Workshops in High Demand
News Feb 06, 2015
Syrris enjoyed another successful global series of flow chemistry seminars in 2014. These free events, which combine theoretical discussion with hands-on sessions, enabled chemists to develop their understanding of the many and varied benefits of flow chemistry.
Flow chemistry has emerged as an exciting technology for research and development chemists over the last decade, enabling a wide variety of chemical reactions to be quickly and easily performed, as well as allowing integration of synthesis, work-up and analysis in a single workflow.
As a market leader in the sector, Syrris has been offering free flow chemistry seminars for three years, and the 2014 series - which included events in Denmark, Switzerland, USA, UK, Germany, Belgium, France, Mexico, Sweden and Japan - proved more popular than ever.
Delegates from a wide range of backgrounds took advantage of the company’s extensive knowledge and experience to learn how to perform reactions that are not possible using traditional techniques, seeing for themselves how flow chemistry can provide safer, faster and cleaner reactions.
Dr Laure Théveau, a postdoctoral fellow at the KTH Royal Institute of Technology, Sweden, attended the Stockholm workshop and commented: “Flow chemistry is becoming increasingly common in scientific literature, and I was keen to learn more about the technique. Both the theoretical and practical sessions were very complementary, combining clear explanations and an overview of the technique with detailed technical information and advice on troubleshooting. I would certainly recommend the workshops to anyone looking at implementing flow chemistry methods in their laboratory.”
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE